Risk of adverse events with bevacizumab addition to therapy in advanced non-small-cell lung cancer: a meta-analysis of randomized controlled trials
2012 ◽
Vol 4
(5)
◽
pp. 849-858
◽
2013 ◽
Vol 2
(1)
◽
pp. 146-150
◽
2014 ◽
Vol 15
(14)
◽
pp. 5691-5696
◽